The Impact of the COVID-19 Pandemic on Patients With CKD: Systematic Review of Qualitative Studies

Am J Kidney Dis. 2023 Oct;82(4):395-409.e1. doi: 10.1053/j.ajkd.2023.04.001. Epub 2023 Jun 16.

Abstract

Rationale & objective: COVID-19 disproportionately affects people with comorbidities, including chronic kidney disease (CKD). We describe the impact of COVID-19 on people with CKD and their caregivers.

Study design: A systematic review of qualitative studies.

Setting & study populations: Primary studies that reported the experiences and perspectives of adults with CKD and/or caregivers were eligible.

Search strategy & sources: MEDLINE, Embase, PsycINFO, CINAHL searched from database inception to October 2022.

Data extraction: Two authors independently screened the search results. Full texts of potentially relevant studies were assessed for eligibility. Any discrepancies were resolved by discussion with another author.

Analytical approach: A thematic synthesis was used to analyze the data.

Results: Thirty-four studies involving 1,962 participants were included. Four themes were identified: exacerbating vulnerability and distress (looming threat of COVID-19 infection, intensifying isolation, aggravating pressure on families); uncertainty in accessing health care (overwhelmed by disruption of care, confused by lack of reliable information, challenged by adapting to telehealth, skeptical about vaccine efficacy and safety); coping with self-management (waning fitness due to decreasing physical activity, diminishing ability to manage diet, difficulty managing fluid restrictions, minimized burden with telehealth, motivating confidence and autonomy); and strengthening sense of safety and support (protection from lockdown restrictions, increasing trust in care, strengthened family connection).

Limitations: Non-English studies were excluded, and inability to delineate themes based on stage of kidney and treatment modality.

Conclusions: Uncertainty in accessing health care during the COVID-19 pandemic exacerbated vulnerability, emotional distress, and burden, and led to reduced capacity to self-manage among patients with CKD and their caregivers. Optimizing telehealth and access to educational and psychosocial support may improve self-management and the quality and effectiveness of care during a pandemic, mitigating potentially catastrophic consequences for people with CKD.

Plain-language summary: During the COVID-19 pandemic, patients with chronic kidney disease (CKD) faced barriers and challenges to accessing care and were at an increased risk of worsened health outcomes. To understand the perspectives about the impact of COVID-19 among patients with CKD and their caregivers, we conducted a systematic review of 34 studies involving 1,962 participants. Our findings demonstrated that uncertainty in accessing care during the COVID-19 pandemic exacerbated the vulnerability, distress, and burden of patients and impaired their abilities for self-management. Optimizing the use of telehealth and providing education and psychosocial services may mitigate the potential consequences for people with CKD during a pandemic.

Keywords: COVID-19; Chronic kidney disease; dialysis; hemodialysis; kidney replacement therapy; patient perspectives; peritoneal dialysis; qualitative research; renal transplantation.

Publication types

  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • COVID-19*
  • Communicable Disease Control
  • Humans
  • Pandemics
  • Qualitative Research
  • Renal Insufficiency, Chronic* / epidemiology
  • Renal Insufficiency, Chronic* / psychology
  • Renal Insufficiency, Chronic* / therapy